Just copied below from latest announcement, successful Monash clinical trial results will be part of ongoing CE submission with the actual approval to follow later? Then we are off to the races in Europe, big market ?
Exciting 2025 ahead for MEM if all goes to plan ?
_______________________________________________________
Regulatory and Commercial Strategy
The trial data will be a key part of Memphasys’ ongoing CE Mark submission, which will allow
immediate commercialisation in Europe
Ann: Felix Clinical Trial complete, Data Lock expected in 2 weeks, page-14
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.934M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $20.37K | 5.083M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 6196027 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 2431903 | 2 |
View Market Depth
| Last trade - 11.08am 17/06/2025 (20 minute delay) ? |
| MEM (ASX) Chart |